Related Experiment Video
Updated: Jul 31, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
[Hemopyrrollactamuria (HPU); from spots to pseudo-disease]
J W van der Meer1, R van de Kerkhof, G K The
1Universitair Medisch Centrum St Radboud, afd. Algemeen Interne Geneeskunde, Postbus 9101, 6500 HB Nijmegen. j.vandermeer@aig.umen.nl
Haemopyrollactamuria (HPU) is a controversial diagnosis in the Netherlands. Scientific literature does not support HPU as a distinct metabolic disease, suggesting it may be a pseudo-disease.
Area of Science:
- Biochemistry
- Metabolic disorders
- Medical diagnostics
Context:
- Patients in the Netherlands are increasingly diagnosed with haemopyrollactamuria (HPU).
- Diagnosis is based on detecting the haemopyrrollactam complex in urine via a commercial laboratory.
- The haemopyrrollactam complex is historically linked to the 'mauve spot' controversy in schizophrenia research.
Purpose:
- To investigate the scientific basis and validity of the haemopyrollactamuria (HPU) diagnosis.
- To review existing literature and data concerning HPU and the haemopyrrollactam complex.
- To determine the appropriate classification of HPU within medical science.
Summary:
- No peer-reviewed scientific literature supports haemopyrollactamuria (HPU) as a distinct metabolic disease.
- The diagnostic marker, the haemopyrrollactam complex, has historical ties to controversial schizophrenia research.
- Based on current evidence, HPU is proposed to be classified as a pseudo-disease.
Impact:
- Challenges the current diagnostic practices and prevalence of HPU in the Netherlands.
- Highlights the need for evidence-based medicine and rigorous scientific validation of new diagnostic markers.
- Encourages critical evaluation of controversial diagnoses and their impact on patient care and scientific understanding.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Atypical Pneumonia
Pneumonia I: Introduction

